FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve™ Single-Cell Gene Expression platform that has the flexibility to capture and analyze hundreds to tens of thousands of individual cells in a broad range of sizes and types. […]
Legacy Experience In Cell Sorting And Enrichment Combined With New Single- Cell And Library Prep Technology Offers Ideal Resolution Of Individual Cells At The Lowest Cost-Per-Answer FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve™ Single-Cell Gene Expression platform […]
Tempe, AZ Biosensing Instrument Inc (BI) introduces today the SPRm 200, the world’s first commercially available surface plasmon resonance microscopy (SPRM) system. The new SPRm 200 is the only scientific solution on the market that enables label-free in vitro measurement of binding reactions and kinetics of individual cells in their native environment. By providing the ability to study […]
CAMBRIDGE, Mass. — Cellaria, LLC, a scientific innovator that develops revolutionary new patient-specific cancer models for challenging tumors, today announced the formation of a strategic partnership with AMS Biotechnology (AMSBIO). As part of the agreement, AMSBIO will distribute, market and sell Cellaria cell models and culture media throughout Europe. The partnership enables Cellaria to better meet growing demand for its […]
CHALFONT ST. GILES, UK and GRAZ/WIEN, AUSTRIA – The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize the Chinese hamster ovary […]
CHALFONT ST. GILES, UK and GRAZ/WIEN, AUSTRIA – The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize the Chinese hamster ovary […]
Sunnyvale, California and Leiden, the Netherlands — In a move to serve customers with ready-to-use solutions for organ-on-a-chip model development and analysis, MIMETAS and Molecular Devices will combine marketing efforts on the OrganoPlate® organ-on-a-chip platform and ImageXpress® Micro Confocal high-content imaging systems. This agreement was announced today at the SLAS2017 conference in Washington. “OrganoPlates® are designed […]
Greiner Bio-One North America, Inc. has added a new and innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™ […]
Greiner Bio-One North America, Inc. has added a new and innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™ […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
